Regulation of COX-2 expression in canine prostate carcinoma: Increased COX-2 expression is not related to inflammation

Journal of Veterinary Internal Medicine

Volumn 21, Issue 4, 2007, Pages 776-782

  L'Eplattenier, Henry F ^a   Lai, Chen Li ^a   Van Den Ham, René ^a   Mol, Jan ^a   Van Sluijs, Frederick ^a   Teske, Erik ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Cell lines; Epithelial growth factor; Immunohistochemistry; Interleukin 6; Phorbol 12 myristate 13 acetate; Tumor necrosis factor alpha

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 6; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CELL LINE; CYTOLOGY; DOG; DOG DISEASE; DRUG EFFECT; ENZYMOLOGY; GENE EXPRESSION REGULATION; INFLAMMATION; MALE; METABOLISM; PROSTATE; PROSTATE TUMOR;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; GENE EXPRESSION REGULATION, NEOPLASTIC; INFLAMMATION; INTERLEUKIN-6; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROTEIN KINASE C; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547759862     PISSN: 08916640     EISSN: None     Source Type: Journal    
DOI: 10.1892/0891-6640(2007)21[776:ROCEIC]2.0.CO;2     Document Type: Article

References (33)

1. Kirschenbaum A, Liu X, Yao S, et al. The role of cyclooxygenase-2 in prostate cancer. Urology 2001;58:127-131.
2. Dubois RN, Abramson SB, Crofford L, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-1073.
3. Kirschenbaum A, Klausner AP, Lee R, et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the human prostate. Urology 2000;56:671-676.
4. Sorenmo KU, Goldschmidt MH, Schofer FS, et al. Evaluation of cyclooxygenase-1 and cyclooxygenase-2 expression and the effect of cyclooxygenase inhibitors in canine prostatic carcinoma. Vet Comp Oncol 2004;2:13-23.
5. Gupta S, Srivastava M, Ahmad N, et al. Over-expression of cyclooxygenase-2 in human prostate adenocarcinoma. Prostate 2000;42:73-78.
6. Hussain T, Gupta S, Mukhtar H. Cyclooxygenase-2 and prostate carcinogenesis. Cancer Lett 2003;191:125-135.
7. Mohammed SI, Khan KN, Sellers RS, et al. Expression of cyclooxygenase-1 and 2 in naturally occurring canine cancer. Prostaglandins Leukot Essent Fatty Acids 2004;70:479-483.
8. Khan KN, Knapp DW, Denicola DB, et al. Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am J Vet Res 2000;61:478-481.
9. Tremblay C, Dore M, Bochsler PN, et al. Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma. J Natl Cancer Inst 1999;91:1398-1403.
10. Johnson AJ, Song X, Hsu A, et al. Apoptosis signaling pathways mediated by cyclooxygenase-2 inhibitors in prostate cancer cells. Adv Enzyme Regul 2001;41:221-235.
11. Madaan S, Abel PD, Chaudhary KS, et al. Cytoplasmic induction and over-expression of cyclooxygenase-2 in human prostate cancer: Implications for prevention and treatment. BJU Int 2000;86:736-741.
12. Wang W, Bergh A, Damber JE. Cyclooxygenase-2 expression correlates with local chronic inflammation and tumor neovascularization in human prostate cancer. Clin Cancer Res 2005;11:3250-3256.
13. Leav I, Ling GV. Adenocarcinoma of the canine prostate. Cancer 1968;22:1329-1345.
14. Cornell KK, Bostwick DG, Cooley DM, et al. Clinical and pathologic aspects of spontaneous canine prostate carcinoma: A retrospective analysis of 76 cases. Prostate 2000;45:173-183.
15. Young RH, Srigley JR, Amin MB, Ulbright TM, Cubilla AL. Tumors of the prostate gland, seminal vesicles, male urethra and penis. In: Atlas of Tumor Pathology (Edited by: Fascicle 28). Washington, DC: Armed Forces Institute of Pathology; 2000, 3: 111-177.
16. Chen JJ, Huang WC, Chen CC. Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen species-mediated signaling pathway and recruitment of CCAAT/enhancer-binding protein delta and CREBbinding protein. Mol Biol Cell 2005;16:5579-5591.
17. Boutemmine D, Bouchard N, Boerboom D, et al. Molecular characterization of canine prostaglandin G/H synthase-2 and regulation in prostatic adenocarcinoma cells in vitro. Endocrinology 2002;143:1134-1143.
18. Arias-Negrete S, Keller K, Chadee K. Proinflammatory cytokines regulate cyclooxygenase-2 mRNA expression in human macrophages. Biochem Biophys Res Commun 1995;208:582-589.
19. Inoue H, Yokoyama C, Hara S, et al. Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells: Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element. J Biol Chem 1995;270:24965-24971.
20. Lin DL, Whitney MC, Yao Z, et al. Interleukin-6 induces androgen responsiveness in prostate cancer cells through upregulation of androgen receptor expression. Clin Cancer Res 2001;7:1773-1781.
21. Culig Z, Bartsch G, Hobisch A. Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 2002;197:231-238.
22. Lin CC, Hsiao LD, Chien CS, et al. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression in human tracheal smooth muscle cells: Involvement of p42/p44 and p38 mitogenactivated protein kinases and nuclear factor-kappaB. Cell Signal 2004;16:597-607.
23. Krajewska M, Krajewski S, Epstein JI, et al. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostatì cancers. Am J Pathol 1996;148:1567-1576.
24. Eaton CL, Pierrepoint CG. Epithelial and fibroblastoid cell lines derived from the normal canine prostate. I. Separation and characterization of epithelial and stromal components. Prostate 1982;3:277-290.
25. Eaton CL, Pierrepoint CG. Epithelial and fibroblastoid cell lines derived from the normal canine prostate. II. Cell proliferation in response to steroid hormones. Prostate 1982;3: 493-506.
26. LeRoy BE, Nadella MV, Toribio RE, et al. Canine prostate carcinomas express markers of urothelial and prostatic differentiation. Vet Pathol 2004;41:131-140.
27. Algarte-Genin M, Cussenot O, Costa P. Prevention of prostate cancer by androgens: Experimental paradox or clinical reality. Eur Urol 2004;46:285-294; discussion 294-285.
28. Webster WS, Small EJ, Rini BI, et al. Prostate cancer immunology: Biology, therapeutics, and challenges. J Clin Oncol 2005;23:8262-8269.
29. Nelson WG, De Marzo AM, DeWeese TL, et al. The role of inflammation in the pathogenesis of prostate cancer. J Urol 2004;172:S6-11; discussion S11-12.
30. Sorenmo KU, Goldschmidt M, Schofer F, et al. Immunohistochemical characterization of canine prostatic carcinoma and correlation with castration status and castration time. Vet Comp Oncol 2003;1:48-56.
31. Hla T, Ristimaki A, Appleby S, et al. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann N Y Acad Sci 1993;696:197-204.
32. Herschman HR. Prostaglandin synthase 2. Biochim Biophys Acta 1996;1299:125-140.
33. Hla T, Bishop-Bailey D, Liu CH, et al. Cyclooxygenase-1 and -2 isoenzymes. Int J Biochem Cell Biol 1999;31:551-557.